Hinova Pharmaceuticals Revenue

In the year 2025, Hinova Pharmaceuticals had annual revenue of 20.67M CNY with 5,535.71% growth. Hinova Pharmaceuticals had revenue of -2.68M in the quarter ending December 31, 2025, a decrease of -1,141.61%.

Revenue

20.67M

Revenue Growth

+5,535.71%

P/S Ratio

201.30

Revenue / Employee

118.81K

Employees

174

Market Cap

4.16B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.67M	20.31M	5,535.71%
Dec 31, 2024	366.84K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	1.65M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Guanhao Biotech	392.83M
Zhejiang Shouxiangu Pharmaceutical	642.66M
Beijing Scitop Bio-tech	351.47M
Zhejiang Wecome Pharmaceutical Company	131.67M
Baolingbao Biology	2.69B
Qingdao Vland Biotech INC.	1.39B
Boji Medical Technology	770.19M
Shenzhen Bioeasy Biotechnology	251.83M

Revenue Rankings